Orchid Pharma Ltd
NSE:ORCHPHARMA
Orchid Pharma Ltd
Total Other Income
Orchid Pharma Ltd
Total Other Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Orchid Pharma Ltd
NSE:ORCHPHARMA
|
Total Other Income
₹77.8m
|
CAGR 3-Years
39%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Total Other Income
₹8.4B
|
CAGR 3-Years
23%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Total Other Income
₹8.2B
|
CAGR 3-Years
44%
|
CAGR 5-Years
19%
|
CAGR 10-Years
16%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Total Other Income
₹18B
|
CAGR 3-Years
25%
|
CAGR 5-Years
17%
|
CAGR 10-Years
19%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Total Other Income
₹722.9m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-9%
|
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Total Other Income
₹768.7m
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Orchid Pharma Ltd
Glance View
Orchid Pharma Ltd. engages in the development, manufacture, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company is headquartered in Chennai, Tamil Nadu. The firm is involved in the development, manufacture and marketing of diverse bulk actives, formulations and nutraceuticals. The company has a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (APIs) and finished dosage forms. The company offers APIs, including Cephalosporins-Orals, Cephalosporins-Injectables, Veterinary Products and Non-Antibodies. Its formulations include Cefixime Capsules, Acarbose Tablets, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Its subsidiaries include Orchid Europe Limited, Orchid Pharmaceuticals Inc., Bexel Pharmaceuticals Inc., and Diakron Pharmaceuticals, Inc., among others.
See Also
What is Orchid Pharma Ltd's Total Other Income?
Total Other Income
77.8m
INR
Based on the financial report for Mar 31, 2024, Orchid Pharma Ltd's Total Other Income amounts to 77.8m INR.
What is Orchid Pharma Ltd's Total Other Income growth rate?
Total Other Income CAGR 5Y
-14%
The average annual Total Other Income growth rates for Orchid Pharma Ltd have been 39% over the past three years , -14% over the past five years .
You don't have any saved screeners yet